The doses will be produced in Bloomington, Indiana by Baxter’s sterile injectable contract manufacturing unit, the companies said in a statement. “This additional production will help us continue to scale up our manufacturing capacity in the United States,” said Juan Andres, Moderna’s Chief Technical Operations and Quality Officer, in a
Moderna has deals with the U.S. government to provide 300 million doses ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.